Russia Biobanking Market Overview, 2029

The systematic way of collection, management, and storage of biological samples and demographic data for use in medical and scientific applications is known as biobanking. These samples includes tissues, blood, DNA, and other biological fluids. The better biological resources provided by biobanks can be used by researchers in many different domains, including genomics, personalized medicine, and the development of medicines. The integration of biobanks into the research and healthcare infrastructures has an opportunity to transform our understanding of diseases and lead to the development of innovative therapies. The market for biobanking has expanded dramatically over the past ten years as a result of developments in biotechnology, an increasing focus on individualized care, and a rise in the demand for high-quality biological samples. In the recent period biobanks become more dependable and efficient because to technological innovations like automated sample storage and complex data management systems. Several trends that are influencing the industry's future include the growing adoption of cloud-based storage solutions as well as cooperation between universities and biobanks. Under Russia, the biobanking industry is expanding gradually, and several initiatives are under progress to establish a robust structure for managing and conserving biological specimens. Across the country, a large number of biobanks are linked to educational institutions, medical facilities, and research institutes.

According to the research report "Russia Biobanking Market Overview, 2029," published by Bonafide Research, the Russia Biobanking market is anticipated to grow at mor than 6.2% CAGR from 2024 to 2029. Sample processing, analysis, and storage capacity increases with the establishment new biobanks and the modernization of existing facilities. The market can increase as a result of expansion since it makes it possible to gather and keep a larger variety and volume of samples. The need for biological samples for study is fueled by Russia's emphasis on biomedical research as well as advances in scientific knowledge and technology. As it makes well-characterized samples and related data accessible to researchers, biobanks are essential in facilitating these kinds of studies. acknowledgement of the role that personalised medicine plays in the healthcare system, which depends on the availability of extensive biobanking resources. The increasing use of personalised medical techniques in Russia has increased the need for high-quality biological samples for the identification of biomarkers and disease.

An extensive range of instruments required for the gathering, processing, storing, and analyzing of samples. Examples of sample storage equipment include centrifuges, automated pipetting systems, robotic platforms for sample processing, and freezers with ultra-low temperatures, cryogenic freezers, and refrigerators. Items that are thrown away yet are essential for biobanking operations are called consumables. Along with storage containers like cryovials and storage boxes, they include kits for collecting samples, such as blood collection tubes, tissue biopsy kits, and DNA extraction kits. Accessories like as PCR tubes and pipette tips are also supplied, along with chemicals and reagents. Manage and track sample information, maintain data integrity, and ease regulatory compliance are all made possible by LIS software systems.


Biological sample collection, processing, storage, and management, together with related data management, constitute the fundamental function of biobanking. A biobank is a facility that stores various sorts of samples, such as blood, tissues, cells, and DNA, also clinical and demographic data. Collection, processing, long-term storage, quality assurance, and data management are a few examples of services that may be provided. Biobanks hold biological samples, and validation and certification services guarantee the samples' dependability, integrity, and quality. include determining the sample's viability, stability, and appropriateness for use in downstream processes. For investigations such as genomic sequencing, proteomics, and histopathology, samples must be appropriately processed, and this is ensured by lab processing services.



Physical biobanks are establishments that preserve biological materials in palpable forms, such tissues, blood, cells, and DNA, under regulated environmental settings. These biobanks keep large collections of samples from individuals, patient groups, and communities, as well as related clinical and demographic information. To maintain sample integrity over time, physical biobanks employ specialized storage technologies such as cryogenic tanks, ultra-low temperature freezers, and automated sample handling systems. By giving researchers access to high-quality samples for a variety of purposes, they play a crucial part in promoting clinical trials, medication development, and biomedical research. Data regarding biological samples and related information are stored in virtual biobanks, often referred to as registry-based biobanks or data-driven biobanks.

Biobanks in Russia play a crucial role in drug discovery and clinical research by providing researchers with access to a wide range of biological samples for studying disease mechanisms, identifying therapeutic targets, and evaluating drug candidates. Researchers use samples from biobanks to conduct preclinical studies, screen for potential drug candidates, and assess drug efficacy and safety in clinical trials. Biobanking supports translational research efforts by facilitating the transition of discoveries from the laboratory to clinical applications. Biobanks contribute to therapeutics development by providing researchers and pharmaceutical companies with access to well-characterized biological samples for developing new therapies and personalized treatment approaches. Samples from biobanks are used to identify biomarkers, stratify patient populations, and evaluate treatment responses in clinical trials. Biobanking supports the development of targeted therapies, immunotherapies, and precision medicine approaches by providing researchers with the necessary resources for translational research and clinical validation. Biobanks play a role in clinical diagnostics by providing healthcare providers with access to biological samples and associated data for diagnostic testing and disease monitoring. Samples from biobanks are used to develop diagnostic assays, validate biomarkers, and improve disease detection and prognostication. Biobanking supports clinical diagnostics by providing researchers and healthcare providers with access to well-characterized patient samples for the development and validation of diagnostic tests, personalized treatment strategies, and disease monitoring protocols.

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• Biobanking market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Equipment
• Consumables
• Laboratory Information Systems

By Service Type
• Biobanking and Repository
• Validation/Qualification
• Lab Processing
• Cold Chain Logistic
• Others

By Biospecimen Type
• Human Tissues
• Stem Cells
• Organs
• Others

By Biobank
• Physical Biobanks
• Virtual Biobanks

By Application
• Drug Discovery and Clinical Research
• Therapeutics
• Clinical Diagnostics
• Others

By Type of Biobank
• Population-based Biobanks
• Disease-oriented Biobanks

By Ownership
• National/regional agency
• Non-Profit Organization
• Universities
• Private Organization

By Storage
• Manual Storage
• Automated Storage

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Biobanking industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.